At 11.8x earnings and 9.5x Forward P/E, MCBS screens optically inexpensive, but the market is clearly pricing in risk, not growth. A PEG Forward of 1.2 suggests only modest growth relative to valuation, while the catastrophic Altman Z-Score of 0.3 signals extreme balance sheet fragility. The combination of a $895M market cap, weak 2.40% ROE, and a Piotroski F-Score of 3 reinforces that this is not a quality compounder but a stressed regional bank trading at a discount for a reason. The low forward multiple implies earnings recovery expectations, yet the credit model risk embedded in that Z-Score makes this a high-risk value play rather than a clean GARP opportunity. The market is not mispricing safety—it is discounting survival risk.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.